22803

    0

    ZENITHDRUG

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ZENITH DRUGS LIMITED Share Price Today

    ZENITH DRUGS LIMITED is currently trading at ₹50.4, up by ₹1.8 from the previous close. The stock touched an intraday high of ₹50.40 and a low of ₹50.40 during the latest trading session. Over the past one year, ZENITH DRUGS LIMITED has delivered a loss of 31.54%, while the stock has gained 11.98% in the last one month.

    ZENITH DRUGS LIMITED performance

    Today’s low Today’s high
    ₹ 50.40 ₹ 50.40
    ₹ 50.40
    52 week low 52 week high
    ₹ 33.30 ₹ 76.00
    ₹ 50.40
    Open Price ₹ 50.40
    Prev. Close ₹ 48.60
    Volume (Shares) 800.00
    Total traded value ₹ .40
    Upper Circuit ₹ 58.30
    Lower Circuit ₹ 38.90
    info

    Investment Returns

    Over 1 Month 11.98% Over 3 Months 12.24% Over 6 Months -1.51% Over 1 Year -31.54%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ZENITH DRUGS LIMITED fundamentals


    • Market cap (Cr) 86.40
    • P/E Ratio (TTM) 21.13
    • Beta 1.25
    • Book Value / share 43.69
    • Return on equity 10.88%
    • EPS (TTM) 2.42
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    ZENITH DRUGS LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 171.22
    Operating Expense 170.72
    Net Profit 3.94
    Net Profit Margin (%) 2.30
    Earnings Per Share (EPS) 2.30
    EBITDA 17.26
    Effective Tax Rate (%) 25.71
    Particulars MAR 2025 (Values in Cr)
    Revenue 133.32
    Operating Expense 126.41
    Net Profit 7.16
    Net Profit Margin (%) 5.37
    Earnings Per Share (EPS) 4.18
    EBITDA 16.18
    Effective Tax Rate (%) 22.08
    Particulars MAR 2024 (Values in Cr)
    Revenue 131.62
    Operating Expense 119.00
    Net Profit 9.54
    Net Profit Margin (%) 7.24
    Earnings Per Share (EPS) 5.56
    EBITDA 19.04
    Effective Tax Rate (%) 25.50
    Particulars MAR 2023 (Values in Cr)
    Revenue 114.52
    Operating Expense 109.10
    Net Profit 4.88
    Net Profit Margin (%) 4.26
    Earnings Per Share (EPS) 122.03
    EBITDA 10.29
    Effective Tax Rate (%) 26.72
    Particulars MAR 2022 (Values in Cr)
    Revenue 91.66
    Operating Expense 88.21
    Net Profit 3.21
    Net Profit Margin (%) 3.50
    Earnings Per Share (EPS) 80.32
    EBITDA 7.88
    Effective Tax Rate (%) 27.04
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.31
    ROE % 24.13
    ROCE % 25.16
    Total Debt to Total Equity 0.63
    EBITDA Margin 12.13
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 443.04
    ROE % 32.74
    ROCE % 24.04
    Total Debt to Total Equity 1.51
    EBITDA Margin 8.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 302.27
    ROE % 25.89
    ROCE % 21.47
    Total Debt to Total Equity 1.56
    EBITDA Margin 8.70
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 40.46
    ROE % 10.88
    ROCE % 12.71
    Total Debt to Total Equity 0.55
    EBITDA Margin 10.81
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.28
    ROE % 26.64
    ROCE % 27.63
    Total Debt to Total Equity 0.62
    EBITDA Margin 13.08
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 443.30
    ROE % 31.92
    ROCE % 24.70
    Total Debt to Total Equity 1.38
    EBITDA Margin 8.99
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 321.27
    ROE % 28.55
    ROCE % 24.14
    Total Debt to Total Equity 1.43
    EBITDA Margin 8.67
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 240.95
    ROE % 37.88
    ROCE % 27.83
    Total Debt to Total Equity 1.70
    EBITDA Margin 9.01
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.80
    Total Assets 135.03
    Total Liabilities 135.03
    Total Equity 62.33
    Share Outstanding 1
    Price to Book Ratio 1.73
    Return on Assets (%) 7.10
    Return on Capital (%) 11.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.27
    Total Assets 97.92
    Total Liabilities 97.92
    Total Equity 17.73
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.98
    Return on Capital (%) 11.13
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 3.00
    Total Assets 68.58
    Total Liabilities 68.58
    Total Equity 12.10
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.57
    Return on Capital (%) 10.15
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.26
    Total Assets 161.47
    Total Liabilities 161.47
    Total Equity 69.37
    Share Outstanding 1
    Price to Book Ratio 1.77
    Return on Assets (%) 4.43
    Return on Capital (%) 6.07
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.74
    Total Assets 134.17
    Total Liabilities 134.17
    Total Equity 62.21
    Share Outstanding 1
    Price to Book Ratio 1.73
    Return on Assets (%) 7.10
    Return on Capital (%) 11.07
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.19
    Total Assets 97.22
    Total Liabilities 97.22
    Total Equity 17.73
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.02
    Return on Capital (%) 11.31
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.88
    Total Assets 66.18
    Total Liabilities 66.18
    Total Equity 12.85
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 4.85
    Return on Capital (%) 10.84
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.84
    Total Assets 46.54
    Total Liabilities 46.54
    Total Equity 9.63
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.58
    Return on Capital (%) 12.21
    Particulars MAR 2024 (Values in Cr)
    Net Income 13.44
    Cash from Operations -8.97
    Cash from Investing 26.00
    Cash from Financing -4.47
    Net change in Cash 8.52
    Free Cash Flow -3.64
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.65
    Cash from Operations -2.94
    Cash from Investing -0.26
    Cash from Financing 4.99
    Net change in Cash -0.04
    Free Cash Flow 2.62
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.40
    Cash from Operations 6.47
    Cash from Investing -5.24
    Cash from Financing 1.24
    Net change in Cash 1.15
    Free Cash Flow 9.05
    Particulars MAR 2025 (Values in Cr)
    Net Income 9.50
    Cash from Operations 0.29
    Cash from Investing -31.40
    Cash from Financing 28.39
    Net change in Cash -8.48
    Free Cash Flow 32.57
    Particulars MAR 2024 (Values in Cr)
    Net Income 13.29
    Cash from Operations -8.84
    Cash from Investing -5.33
    Cash from Financing 29.71
    Net change in Cash 8.54
    Free Cash Flow -7.42
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.65
    Cash from Operations -2.44
    Cash from Investing -2.04
    Cash from Financing 6.30
    Net change in Cash -0.01
    Free Cash Flow -0.76
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.40
    Cash from Operations 6.15
    Cash from Investing -3.04
    Cash from Financing -0.82
    Net change in Cash 1.04
    Free Cash Flow 8.72
    Particulars MAR 2021 (Values in Cr)
    Net Income 4.60
    Cash from Operations 0.47
    Cash from Investing -1.42
    Cash from Financing 2.88
    Net change in Cash 0.56
    Free Cash Flow 1.90
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.00 12.86 1.50 237.56 23.12 38.85
    BLISS GVS PHARMA LTD. 489.35 39.34 4.35 5189.86 118.35 552.90
    CIPLA LTD. 1441.45 30.59 3.38 116446.86 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 443.20 19.55 3.20 1304.38 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.00 21.68 3.99 237.56 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 546.40 24.49 4.26 1579.68 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8063.60 105.31 23.09 20159.00 7630.00 9850.00
    BLISS GVS PHARMA LTD. 489.35 52.90 4.49 5189.86 118.35 552.90

    ZENITH DRUGS LIMITED shareholding pattern

    Holding
    30.02%
    69.97%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ZENITH DRUGS LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    50.40 3.70 redarrow
    red-green-graph indicator
    6 Bearish
    10 Bullish
    • 5 Days 50.20
    • 26 Days 47.90
    • 10 Days 50.00
    • 50 Days 46.00
    • 12 Days 49.80
    • 100 Days 46.10
    • 20 Days 48.60
    • 200 Days 51.00
    48.60 PIVOT
    First Support 48.60 First Resistance 48.60 Second Support 48.60 Second Resistance 48.60 Third Support 48.60 Third Resistance 48.60
    RSI 52.20 ADX 25.33 MACD 1.92 Williams % R -53.00 Commodity Channel Index (CCI) 8.24
    Date 2026-07-20 Week 2720.00 Same Day 2400.00 Month 10526.00
    1 Year 1.25 3 Year 1.12
    Over 1 Month
    11.98% down
    Over 1 Year
    -31.54% down
    Over 3 Months
    12.24% down
    Over 3 Years
    -22.68% down
    Over 6 Months
    -1.51% down
    Over 5 Years
    0.00% down

    ZENITH DRUGS LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Sep 2024 0.5 Final 18 Sep 2024 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Zenith Drugs Ltd?

    Answer Field

    Zenith Drugs Ltd share price is for NSE ₹ 50.40 & for BSE ₹ 0.00 as on Jul 21 2026 10:17 AM.

    What is the Market Cap of Zenith Drugs Ltd Share?

    Answer Field

    The market cap of Zenith Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 21 2026 10:17 AM.

    What is the 52 Week High and Low of Zenith Drugs Ltd?

    Answer Field

    The 52 Week High and Low of Zenith Drugs Ltd for NSE is ₹ 76.00 and ₹ 33.30 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Zenith Drugs Ltd?

    Answer Field

    The 1 year returns on the stock has been -31.54%.

    What is the P/E Ratio of Zenith Drugs Ltd Share?

    Answer Field

    As on Jul 21 2026 10:17 AM the price-to-earnings (PE) ratio for Zenith Drugs Ltd share is 21.13.

    What is the PB ratio of Zenith Drugs Ltd Share?

    Answer Field

    As on Jul 21 2026 10:17 AM, the price-to-book (PB) ratio for Zenith Drugs Ltd share is 43.69.

    How to Buy Zenith Drugs Ltd Share?

    Answer Field

    You can trade in Zenith Drugs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Zenith Drugs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Zenith Drugs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Zenith Drugs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |